TWD
AGIO icon

True Wealth Design’s Agios Pharmaceuticals AGIO Stock Holding History

True Wealth Design’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4K Buy
306
+294
+2,450% +$8.92K ﹤0.01% 1023
2026
Q1 		$406 Buy
+12
New +$340 ﹤0.01% 2121
2025
Q4 		– Sell
-9
Closed -$362 – 2562
2025
Q3 		$362 Hold
9
– – ﹤0.01% 2111
2025
Q2 		$300 Buy
9
+4
+80% +$121 ﹤0.01% 1934
2025
Q1 		$147 Buy
+5
New +$166 ﹤0.01% 2069
2024
Q4 		– Sell
-166
Closed -$7.38K – 1354
2024
Q3 		$7.38K Buy
+166
New +$7.54K ﹤0.01% 478

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

True Wealth Design's AGIO Position: Q2 2026 in Review

True Wealth Design increased its Agios Pharmaceuticals (AGIO) stake by 2,450% in Q2 2026, buying an estimated $8.92K and bringing the position to 306 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1023.

True Wealth Design first reported a position in AGIO in Q3 2024 and has held it in 6 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • True Wealth Design held 306 shares of Agios Pharmaceuticals worth $11.4K as of Q2 2026.
  • True Wealth Design bought 294 Agios Pharmaceuticals shares in Q2 2026, an estimated $8.92K.
  • Agios Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1023 holding.
  • True Wealth Design first reported a position in Agios Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.